Journal article 1203 views
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
C Mathieu,
P Hollander,
B Miranda-Palma,
J Cooper,
E Franek,
D Russell-Jones,
J Larsen,
S. C Tamer,
S. C Bain,
Steve Bain 
Journal of Clinical Endocrinology & Metabolism, Volume: 98, Issue: 3, Pages: 1154 - 1162
Swansea University Author:
Steve Bain
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1210/jc.2012-3249
Abstract
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
| Published in: | Journal of Clinical Endocrinology & Metabolism |
|---|---|
| ISSN: | 0021-972X |
| Published: |
2013
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa16198 |
| first_indexed |
2013-09-26T11:46:18Z |
|---|---|
| last_indexed |
2018-02-09T04:48:45Z |
| id |
cronfa16198 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2013-09-23T07:40:41.9710375</datestamp><bib-version>v2</bib-version><id>16198</id><entry>2013-09-23</entry><title>Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2013-09-23</date><deptcode>MEDS</deptcode><abstract></abstract><type>Journal Article</type><journal>Journal of Clinical Endocrinology & Metabolism</journal><volume>98</volume><journalNumber>3</journalNumber><paginationStart>1154</paginationStart><paginationEnd>1162</paginationEnd><publisher/><placeOfPublication/><issnPrint>0021-972X</issnPrint><issnElectronic/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2013</publishedYear><publishedDate>2013-12-31</publishedDate><doi>10.1210/jc.2012-3249</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2013-09-23T07:40:41.9710375</lastEdited><Created>2013-09-23T07:40:41.9710375</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>C</firstname><surname>Mathieu</surname><order>1</order></author><author><firstname>P</firstname><surname>Hollander</surname><order>2</order></author><author><firstname>B</firstname><surname>Miranda-Palma</surname><order>3</order></author><author><firstname>J</firstname><surname>Cooper</surname><order>4</order></author><author><firstname>E</firstname><surname>Franek</surname><order>5</order></author><author><firstname>D</firstname><surname>Russell-Jones</surname><order>6</order></author><author><firstname>J</firstname><surname>Larsen</surname><order>7</order></author><author><firstname>S. C</firstname><surname>Tamer</surname><order>8</order></author><author><firstname>S. C</firstname><surname>Bain</surname><order>9</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>10</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2013-09-23T07:40:41.9710375 v2 16198 2013-09-23 Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2013-09-23 MEDS Journal Article Journal of Clinical Endocrinology & Metabolism 98 3 1154 1162 0021-972X 31 12 2013 2013-12-31 10.1210/jc.2012-3249 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2013-09-23T07:40:41.9710375 2013-09-23T07:40:41.9710375 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine C Mathieu 1 P Hollander 2 B Miranda-Palma 3 J Cooper 4 E Franek 5 D Russell-Jones 6 J Larsen 7 S. C Tamer 8 S. C Bain 9 Steve Bain 0000-0001-8519-4964 10 |
| title |
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension |
| spellingShingle |
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension Steve Bain |
| title_short |
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension |
| title_full |
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension |
| title_fullStr |
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension |
| title_full_unstemmed |
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension |
| title_sort |
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension |
| author_id_str_mv |
5399f4c6e6a70f3608a084ddb938511a |
| author_id_fullname_str_mv |
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
| author |
Steve Bain |
| author2 |
C Mathieu P Hollander B Miranda-Palma J Cooper E Franek D Russell-Jones J Larsen S. C Tamer S. C Bain Steve Bain |
| format |
Journal article |
| container_title |
Journal of Clinical Endocrinology & Metabolism |
| container_volume |
98 |
| container_issue |
3 |
| container_start_page |
1154 |
| publishDate |
2013 |
| institution |
Swansea University |
| issn |
0021-972X |
| doi_str_mv |
10.1210/jc.2012-3249 |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
2013-12-31T06:31:14Z |
| _version_ |
1822020206546911232 |
| score |
11.085372 |